Your browser doesn't support javascript.
loading
Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature.
Ammari, Zaid; Pak, Stella C; Ruzieh, Mohammed; Dasa, Osama; Tiwari, Abhinav; Jaume, Juan C; Alfonso-Jaume, Maria A.
Afiliación
  • Ammari Z; Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
  • Pak SC; Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
  • Ruzieh M; Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
  • Dasa O; Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
  • Tiwari A; Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
  • Jaume JC; Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
  • Alfonso-Jaume MA; Division of Endocrinology, Diabetes and Metabolism, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
Case Rep Endocrinol ; 2018: 4606491, 2018.
Article en En | MEDLINE | ID: mdl-29854487
ABSTRACT
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Endocrinol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Endocrinol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos